Significance of Aspirin and Clopidogrel Resistance in Patients Undergoing Percutaneous Coronary Interventions

By  

Current Vascular Pharmacology, Vol. 5, Iss. 2, 2007-04 ,pp. : 135-140

Bentham Science Publishers

Access to resources Recommend Favorite

Japanese postmarketing surveillance of clopidogrel for patients with non-ST-segment-elevation acute coronary syndrome indicated for percutaneous coronary intervention (J-PLACE NSTE-ACS)

By Morino Yoshihiro   Ako Junya   Kobayashi Masayuki   Nakamura Masato  

Cardiovascular Intervention and Therapeutics, Vol. 29, Iss. 2, 2014-04 ,pp. : 123-133

Springer Publishing Company

Access to resources Recommend Favorite

Factors Associated With Initial Prasugrel Versus Clopidogrel Selection for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From the Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE‐ACS) Study

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 9, 2016-09 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention

By Smith Simon M.G.   Judge Heather M.   Peters Gary   Storey Robert F.  

Platelets, Vol. 15, Iss. 8, 2004-12 ,pp. : 465-474

Informa Healthcare

Access to resources Recommend Favorite

Relation between the Change in Mean Platelet Volume and Clopidogrel Resistance in Patients Undergoing Percutaneous Coronary Intervention

By  

Current Vascular Pharmacology, Vol. 13, Iss. 5, 2015-01 ,pp. : 687-693

Bentham Science Publishers

Access to resources Recommend Favorite